台灣外科醫學會雜誌

中文 | ENG

	第58卷第1期 2025-1 Ensuring authorship qualification in clinical research articles: A focus on surgical therapy studies
.........................
	第58卷第1期 2025-1 Estimated risk for transfusion of monkeypox contaminated perioperative blood transfusion: A call to action for stronger regulations and testing protocols
.........................
	第58卷第1期 2025-1 Insights into traumatic and crisis surgery: Implications of data analysis in conflict zones
.........................
	第58卷第1期 2025-1 Tongue peeling as an adverse reaction with use of micronized purified flavonoid: A case report
.........................
	第58卷第1期 2025-1 Pilonidal sinus of scrotum: A rare clinical entity
.........................
	第58卷第1期 2025-1 Incidental autopsy finding of retiform hemangioendothelioma of the spleen
.........................
	第58卷第1期 2025-1 Retroperitoneal laparoscopy for hydronephrosis due to multiple fibroepithelial polyps: A case series
.........................
	第58卷第1期 2025-1 Case reports of type 1 cystic biliary atresia—A rare variant of biliary atresia alongwith reviewof literature
.........................
	第58卷第1期 2025-1 The predictors of intraoperative surgical expenses in liver resection for hepatocellular carcinoma
.........................
	第58卷第1期 2025-1 Intracorporeal anastomosis versus extracorporeal anastomosis following laparoscopic right hemicolectomy: Surgical outcomes of a single-center observational study
.........................
	第58卷第1期 2025-1 Quality of life and spiritual health in motorcycle accident survivors: An analysis using the SF-36 Questionnaire and Spiritual Scale
.........................
	第58卷第1期 2025-1 Plastin 3 expression in circulating tumor cells as a predictor of cancer status in patients with prostate cancer
.........................
	第57卷第6期 2024-11 Emerging robot-guided techniques in endodontic microsurgery
.........................
	第57卷第6期 2024-11 Management of subcapsular hematoma after living donor liver transplant
.........................
	第57卷第6期 2024-11 Urethral pseudodiverticulum with left-sided nonfunctioning kidney: Case report
.........................
	第57卷第6期 2024-11 Strategy to minimize surgical defect of dermatofi brosarcoma protuberans
.........................
	第57卷第6期 2024-11 Rapunzel syndrome—An uncommon disease with varied common presentations
.........................
	第57卷第6期 2024-11 Minimally invasive approaches to management of acute necrotizing pancreatitis
.........................
	第57卷第6期 2024-11 Innovative surgical technique: Addressing ethical concerns
.........................
	第57卷第6期 2024-11 Emergency surgery and HIV screening, clinical or universal scenarios?
.........................

登入帳號才能閱讀全文

篇名	Purification and characterization of type AI arginase with immune inhibitory activity: Potential for the treatment of transplant rejection
作者	Soo-Ray Wang
卷期/出版年月	35卷2期 (2002/4)
頁次	59-66
摘要	A protein obtained from mammalian livers capable of inhibiting mitogen-induced lymphocyte proliferation, is called “liver-derived inhibitory protein”, or has been purified from mouse ;over homogenates and was proven to be arginase. Arginase in mammalian body has two isoforms, type I is liver orgin (i.e. LIP), type II exists in other tissues of the body. LIP can inhibit boyh Y- and B-lymphocytes. It is temperature stable up to 65℃ and PH stable from 3 to 11. LIP molecular weight is 105 kDa. The immune inhibitory property of liver arginase is due to arginine depletion resulting in suppression of syntheses of thymidine kinase and uridine kinase which have a half of only two hours; hence the DNA and RNA syntheses are inhibited and cell proliferation is suppressed. Liver arginase is the only mammalian amino acid-degradation enzyme that can potently inhibit lymphocyte proliferation. Because lymphocyte inhibition by liver arginase is reversible and is of non-cytotoxic, it is conceivable that liver arginase of human origin has a great potential of therapeutical benefit in treating transplant rejection.
關鍵詞
分類	Overview